The Neurosurgical Oncology division at UAMS provides multidisciplinary state of the art care for patients with brain and spine tumors.  Our program includes neurosurgeons, a neuro-oncologist, radiation oncologists, a neuropathologist, neuro-psychologists, neuro-interventional radiologists, and specialized nurses. All of our neurosurgeons who remove brain and spine tumors are fellowship trained.  Certain complex neurosurgical cases are done in combination otolaryngology or orthopedic surgery (Link: https://medicine.uams.edu/news/surgeons-team-up-to-remove-pituitary-gland-tumor/).  UAMS has the only fellowship trained neuro-oncologist in the state.  This training allows us to ensure our patients are receiving the best up to date care available.   Each patient is carefully evaluated by our team to determine the best treatment plan.  We evaluate patients for both surgical and nonsurgical management.  We treat patients with both primary and secondary brain and spine tumors.

The department of neurosurgery offers techniques that are not offered elsewhere in the state of Arkansas.   These techniques include the following:  advanced endoscopy, robotic stereotaxis, BrainPath, laser thermal ablation, and gamma knife radiosurgery.  Patients are also screened for enrollment in clinical trials.  Dr. Rodriguez, director of neurosurgical oncology, and Dr. Day, Chair of Neurosurgery, have implemented tumor tissue banking.  This allows us to analyze patient tissue to develop targeted therapy.

Research and Clinic Trials

Several physicians in our neuro-oncology team have translational research laboratories.  Dr. Fen Xia, Chair of Radiation Oncology, and Dr. Analiz Rodriguez, director of neurosurgical oncology, both have laboratories that investigate novel methods to target glioblastoma.  Dr. Xia also studies brain metastases including new therapies for patients with stage IV breast cancer.

(Links: http://radonc.uams.edu/research/translational-research/dr-xias-lab-and-lab-work/research/

https://uamshealth.com/news/tag/seeds-of-science/)

 

UAMS  also offers clinical trials for brain tumor patients.  Dr. Day, Chair of Neurosurgery, was the first surgeon in the nation to inject a new cold virus into a glioblastoma. (https://uamshealth.com/news/2016/11/15/first-time-in-us-virus-used-to-attack-brain-tumor/) .  Dr. Day specializes in removing tumors in difficult to access locations.  As a surgical innovator, his goal is to combine advanced surgical techniques with targeted therapies for malignant brain tumors.  This approach is only available in a handful of institutions in the nation.